The OC3
Funding
|
Sponsor |
American Cancer Society |
| Description |
Research Scholar Award |
|
Grant dates |
Jul. 1, 2022 – Jun. 30, 2026 |
|
Title |
Pre- and Post-Diagnosis Metformin Use and Ovarian Cancer Survival |
|
Principal Investigator |
Holly Harris (Fred Hutchinson Cancer Center) |
|
Sponsor |
National Cancer Institute |
| Description |
Small Grant (R03) |
|
Grant dates |
Mar. 7, 2022 – Feb. 28, 2024 |
|
Title |
Using Biomarkers to Elucidate the Breastfeeding and Ovarian Cancer Risk Association |
|
Principal Investigator |
Naoko Sasamoto (Brigham and Women's Hospital) |
|
Sponsor |
National Cancer Institute |
| Description |
Small Grant (R03) |
|
Grant dates |
Feb. 1, 2022 – Jan. 31, 2024 |
|
Title |
Type II diabetes, related biomarkers and medication, and ovarian cancer risk |
|
Principal Investigator |
Holly Harris (Fred Hutchinson Cancer Center) |
|
Sponsor |
Department of Defense Ovarian Cancer Research Program |
| Description |
Ovarian Cancer Academy Award |
|
Grant dates |
Jan. 31, 2022 – Sep. 29, 2025 |
|
Title |
Aspirin and NSAID Use and Ovarian Cancer Prognosis: A Molecular Epidemiological Study |
|
Principal Investigator |
Melissa Merritt (University of Sydney) |
|
Sponsor |
National Cancer Institute |
|
Description |
Research Project Grant (R01) |
|
Grant dates |
Apr. 1, 2021 – Mar. 31, 2026 |
|
Title |
Changing Contraceptive Patterns and Ovarian Cancer Risk |
|
Principal Investigator |
Kathryn Terry (Brigham and Women's Hospital) |
|
|
|
|
Sponsor |
National Cancer Institute |
|
Description |
Research Project-Cooperative Agreement (U01) Administrative Supplement |
|
Grant dates |
Sept. 1, 2020 - Aug. 31, 2021 |
|
Title |
Understanding Ethnic Differences in Cancer: The Multiethnic Cohort Study |
|
Principal Investigator |
Melissa Merritt (University of Hawaii) |
|
|
|
|
Sponsor |
Department of Defense Ovarian Cancer Research Program |
|
Description |
Investigator-Initiated Research Award |
|
Grant dates |
Sept. 15, 2019 - Sept. 14, 2022 |
|
Title |
Making the CASE: Chemopreventive use of ASpirin for ovarian cancer - integrating Epidemiological data to evaluate population subgroups and tumor expression |
|
Principal Investigator |
Britton Trabert (National Cancer Institute) |
|
|
|
|
Sponsor |
Department of Defense Ovarian Cancer Research Program |
|
Description |
Translational Leverage Award |
|
Grant dates |
Sept. 29, 2012 - Sept. 28, 2015 |
|
Title |
Development of the Ovarian Cancer Cohort Consortium: Risk factor associations by heterogeneity of disease |
|
Principal Investigator |
Shelley Tworoger (Brigham and Women's Hospital) |